Month: August 2020

SEATTLE, Aug. 10, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming UBS Genomics 2.0 and Medtech Innovations Virtual Summit.Adaptive Biotechnologies’ management is scheduled to participate in a fireside chat on Tuesday, August 11th at 11:00 a.m. Pactific Time / 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.About Adaptive BiotechnologiesAdaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive...

Interim 8-Week Top-Line Data From Etokimab ECLIPSE Phase 2 Trial in Chronic Rhinosinusitis with Nasal Polyps Did Not Demonstrate Statistical Significance For Either Q4W or Q8W Versus Placebo; Company Plans To Assess Path Forward for Etokimab After Complete 16-Week Trial Data by year-end 2020Following Orphan Drug Designation by the FDA, Additional Topline Data from GALLOP Phase 2 Clinical Trial of Imsidolimab Monotherapy in Moderate-to-Severe Generalized Pustular Psoriasis on Track for Fourth Quarter 2020Topline Data from POPLAR Phase 2 Clinical Trial of Imsidolimab Monotherapy in Palmoplantar Pustulosis Anticipated in First Quarter 2021Expansion of Imsidolimab Program Into Two New Clinical Indications, EGFRi-Mediated Skin Toxicities and Ichthyosis, With Phase 2 Trials To Be Initiated in Fourth Quarter 2020Healthy Volunteer Phase 1 Clinical...

REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the following investor virtual conferences.UBS Genomics 2.0 and Medtech Innovations SummitFireside Chat on Tuesday, August 11th at 9 a.m. Pacific Time / 12 p.m. Eastern TimeCanaccord Virtual Growth ConferenceFireside Chat on Thursday, August 13th at 1 p.m. Pacific Time / 4 p.m. Eastern TimeInterested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.About Guardant HealthGuardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages...

Fort Worth, TX, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — ADM Endeavors, Inc. (OTCQB: ADMQ) CEO, Marc Johnson, has completed the purchase of 347,635 shares of common stock on the open market in a demonstration of his long-term belief in the Company’s growth plan. (http://www.admendeavors.com)Mr. Johnson said that his optimism in the Company, its potential growth and long-term success, prompted him to purchase shares of common stock on the open market. He explained the shares he purchased are classified as affiliate shares, and therefore have the regulatory restrictions associated with them.The purchase of these shares has been disclosed by Mr. Johnson in a Form 4 as required by the U.S. Securities and Exchange Commission. The Company currently has 160,902,143 common shares outstanding and a float totaling 53,270,000...

CINCINNATI, Aug. 10, 2020 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases, ARDS associated with COVID-19, and diabetic complications, will release its financial results for the second quarter ended June 30, 2020, before the market open on Wednesday, August 12, 2020, and host a webcast and conference call at 8:30am ET.Wednesday, August 12th @ 8:30amETInvestors:                                877-407-9716International Investors:           201-493-6779Conference ID:                       13707708Audio-Only Webcast:              http://public.viavid.com/index.php?id=141035 About Aerpio PharmaceuticalsAerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate...

ATLANTA, Aug. 10, 2020 (GLOBE NEWSWIRE) — Select Interior Concepts, Inc. (“SIC” or the “Company”) (NASDAQ: SIC), a premier installer and nationwide distributor of interior building products, today announced the appointment of Deme Christian as Chief Human Resources Officer, effective immediately.“Strengthening SIC’s corporate infrastructure is critical to optimizing the Company’s revenue growth and core earning power, and appointing Deme, a seasoned, high-caliber human resources leader, is an important step toward that objective,” said L.W. (Bill) Varner, Jr., Chief Executive officer of SIC. “Of relevance, she has a wealth of experience driving human capital strategies for multi-site organizations and proven success at team building, organizational design and human capital planning, including the integration of acquired companies....

NEWARK, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — ShotSpotter, Inc. (NASDAQ: SSTI), the leader in acoustic gunshot detection and precision policing solutions that help law enforcement officials and security personnel prevent and reduce gun violence, will be presenting at the Canaccord Genuity 40thAnnual Growth Conference. The conference is being held virtually on August 11-13, 2020.ShotSpotter management is scheduled to present on Wednesday, August 12 at 9:30 a.m. Eastern time. The presentation will be webcast and available for replay here. Management will also hold one-on-one meetings with institutional investors and analysts throughout the day.To receive additional information or to schedule a one-on-one meeting, please contact ShotSpotter’s IR team at SSTI@gatewayir.com.    About ShotSpotter, Inc.ShotSpotter (NASDAQ: SSTI) provides...

NORCROSS, Ga., Aug. 10, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the quarter ended June 30, 2020. These results are included in the Company’s Quarterly Report on Form 10-Q, which has been filed with the U.S. Securities and Exchange Commission and is available at www.sec.gov.Harold H. Shlevin, Ph.D., President and Chief Executive Officer of Galectin Therapeutics, said, “We are excited to have initiated the NASH-RX trial, having enrolled our first patient in June and continuing to enroll patients at several of our sites in our clinical trial of belapectin targeting cirrhotic NASH patients. If the results of the NASH-RX trial are compelling, there could be the potential...

ATLANTA, Aug. 10, 2020 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company,” “CUMULUS MEDIA,” “we,” “us,” or “our”) today announced operating results for the three and six months ended June 30, 2020.Mary G. Berner, President and Chief Executive Officer of CUMULUS MEDIA, said, “Despite the COVID-19 pandemic’s material impact on revenue, the Company generated over $90 million of cash in the quarter through quick and decisive expense actions, strong working capital management and the completion of the sale of land in Bethesda, MD. Ending the quarter with nearly $200 million of cash, we have also entered into an agreement to monetize our tower portfolio for more than $210 million, proceeds which will further add to our liquidity and contribute to significant incremental debt paydown. Our demonstrated...

NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — Aspen Group, Inc. (“AGI”) (Nasdaq: ASPU), an education technology holding company, today announced a quarterly record of 2,351 new student enrollments in the fiscal 2021 first quarter ending July 31, 2020, a sequential increase of 32%, and 22% year-over-year. Quarterly bookings increased sequentially by 39%, and by 34% year-over-year from $26.9 million to $36.1 million.Aspen University generated 1,779 new student enrollments in the first quarter of fiscal year 2021, up 26% over the prior year. The strong enrollment growth at Aspen University was a result of record quarterly enrollments in its Doctoral and BSN Pre-Licensure units.United States University (“USU”) also delivered record enrollments in the first quarter with 572 new student enrollments driven primarily by MSN-Family Nurse Practitioner...